Patent details
LUC50046 Product Name: Forme cristalline d'un sel d'hydrobromure de nirogacestat, de préférence une forme cristalline du sel de dihydrobromure de nirogacestat
Basic Information
- Publication number:
- LUC50046
- Type:
- SPC
- SPC Type:
- Medical
- Basic Patent Number:
- EP197585896
- Legal Status:
- Pending & Published
- Application number:
- LUC50046
- First applicant's nationality:
- Procedural language:
- French
Marketing Authorization
- Marketing Authorization Number:
- EU/1/25/1932
- Marketing Authorization Type:
- Marketing Authorization Date:
- 18/08/2025
- Marketing Authorization Status:
- Accepted
- Marketing Authorization Country:
- Luxembourg (LU)
Dates
- Filing date:
- 18/03/2026
- First Marketing Authorization date:
- 18/08/2025
- Grant date:
- Activation date:
- Publication date:
- 18/03/2026
- Lapsed date:
- Expiration date:
- Renunciation date:
- Revocation date:
- Annulment date:
- Basic SPC Expiration:
- 18/08/2040
- SPC Extension Expiration:
- 18/08/2040
- Rejection date:
- Withdrawal date:
Owner
- From:
- 18/03/2026
- Name:
- Pfizer Inc.
- Address:
- 66 Hudson Boulevard East, New York, NY 10001-2192, United States (US)
Agent
- Name:
- OFFICE FREYLINGER S.A.
- From:
- 18/03/2026
- Address:
- Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
- To:
| Filing date | Document type | Number of pages |
|---|---|---|
| 18/03/2026 | Application Form | 5 |
| 18/03/2026 | Outgoing Correspondence | 2 |
| 18/03/2026 | General Document | 12 |
| 18/03/2026 | General Document | 43 |
| 18/03/2026 | General Document | 1 |
| 18/03/2026 | General Document | 3 |
| 18/03/2026 | Outgoing Correspondence | 1 |